Seelos Therapeutics Inc (NASDAQ:SEEL)
| 0.9705 Delayed Data As of 3:59pm ET |  +0.0285 / +3.03%Today’s Change | 0.72 Today|||52-Week Range 10.44 | -83.15% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 0.94 |
| Today’s open | 0.94 |
| Day’s range | 0.93 - 1.09 |
| Volume | 1,416,355 |
| Average volume (3 months) | 343,743 |
| Market cap | $23.4M |
Data as of 3:59pm ET, 12/05/2019
Growth & Valuation
| Earnings growth (last year) | +59.87% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.32 |
Competitors
| ---- | ||
| BNGOBionano Genomics Inc | +0.18 | +19.13% |
| CLBSCaladrius Bioscience... | +0.03 | +1.18% |
| INNTInnovate Biopharmace... | -0.03 | -3.36% |
Data as of 4:00pm ET, 12/05/2019
Financials
| Next reporting date | March 18, 2020 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
